| Author | Willems, Luc | |
| Author | Hasegawa, Hideki | |
| Author | Accolla, Roberto | |
| Author | Bangham, Charles | |
| Author | Bazarbachi, Ali | |
| Author | Bertazzoni, Umberto | |
| Author | Proietti, Anna Barbara de Freitas Carneiro | |
| Author | Cheng, Hua | |
| Author | Bianchi, Luigi Chieco | |
| Author | Ciminale, Vincenzo | |
| Author | Reis, Jordana Grazziela Alves Coelho dos | |
| Author | Esparza, Jose | |
| Author | Gallo, Robert C. | |
| Author | Gessain, Antoine | |
| Author | Gotuzzo, Eduardo | |
| Author | Hall, William | |
| Author | Harford, Joseph | |
| Author | Hermine, Olivier | |
| Author | Jacobson, Steven | |
| Author | Macchi, Beatrice | |
| Author | Macpherson, Calum | |
| Author | Mahieux, Renaud | |
| Author | Matsuoka, Masao | |
| Author | Murphy, Edward | |
| Author | Peloponese, Jean-Marie | |
| Author | Simon, Viviana | |
| Author | Tagaya, Yutaka | |
| Author | Taylor, Graham P | |
| Author | Watanabe, Toshiki | |
| Author | Yamano, Yoshihisa | |
| Access date | 2018-06-28T14:09:11Z | |
| Available date | 2018-06-28T14:09:11Z | |
| Document date | 2017 | |
| Citation | WILLEMS, Luc et al. Reducing the global burden of HTLV-1 infection: An agenda for research and action. Antiviral Research, v. 137, p. 41-48, 2017 | pt_BR |
| ISSN | 0166-3542 | pt_BR |
| URI | https://www.arca.fiocruz.br/handle/icict/27168 | |
| Language | eng | pt_BR |
| Publisher | Elsevier B.V | pt_BR |
| Rights | restricted access | pt_BR |
| Subject in Portuguese | HTLV-1 | pt_BR |
| Subject in Portuguese | vacina | pt_BR |
| Title | Reducing the global burden of HTLV-1 infection: An agenda for research and action | pt_BR |
| Type | Article | |
| DOI | 10.1016/j.antiviral.2016.10.015 | |
| Abstract | Even though an estimated 10e20 million people worldwide are infected with the oncogenic retrovirus, human T-lymphotropic virus type 1 (HTLV-1), its epidemiology is poorly understood, and little effort hás been made to reduce its prevalence. In response to this situation, the Global Virus Network launched a taskforce in 2014 to develop new methods of prevention and treatment of HTLV-1 infection and promote basic research. HTLV-1 is the etiological agent of two life-threatening diseases, adult T-cell leukemia and HTLV-associated myelopathy/tropical spastic paraparesis, for which no effective therapy is currently available. Although the modes of transmission of HTLV-1 resemble those of the more familiar HIV-1, routine diagnostic methods are generally unavailable to support the prevention of new infections. | pt_BR |
| Affilliation | University of Liege. Belgium/Chairs of the HTLV Taskforce of the Global Virus Network. USA | pt_BR |
| Affilliation | National Institute of Infectious Diseases. Tokyo, Japan/Chairs of the HTLV Taskforce of the Global Virus Network. USA | pt_BR |
| Affilliation | University of Insubria. Varese, Italy | pt_BR |
| Affilliation | Imperial College. London, UK | pt_BR |
| Affilliation | American University of Beirut. Beirut, Lebanon | pt_BR |
| Affilliation | University of Verona. Verona, Italy | pt_BR |
| Affilliation | Fundaçao Hemominas. Belo Horizonte, MG, Brazil | pt_BR |
| Affilliation | Institute of Human Virology. Baltimore, USA | pt_BR |
| Affilliation | University of Padova, Padova. Italy | pt_BR |
| Affilliation | University of Padova, Padova. Italy | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Rene Rachou. Belo Horizonte, MG, Brazil | pt_BR |
| Affilliation | Institute of Human Virology. Baltimore, USA | pt_BR |
| Affilliation | Institute of Human Virology. Baltimore, USA | pt_BR |
| Affilliation | Institut Pasteur. Paris, France | pt_BR |
| Affilliation | Tropical Medical Institute Alexander von Humboldt. Lima, Peru | pt_BR |
| Affilliation | Centre for Research in Infectious Disease. Dublin, Ireland | pt_BR |
| Affilliation | National Cancer Institute. NIH. Bethesda, USA | pt_BR |
| Affilliation | Hospital Necker. Paris, France | pt_BR |
| Affilliation | National Institute of Neurological Disorders and Stroke. NIH. Bethesda, USA | pt_BR |
| Affilliation | University of Rome Tor Vergata. Rome, Italy | pt_BR |
| Affilliation | St. George's University. Grenada | pt_BR |
| Affilliation | Ecole Normale Superieure de Lyon. Lyon, France | pt_BR |
| Affilliation | Kyoto University. Kyoto, Japan | pt_BR |
| Affilliation | University of California. San Francisco, CA, USA | pt_BR |
| Affilliation | University of Montpellier. Montpellier, France | pt_BR |
| Affilliation | Icahn School of Medicine at Mount Sinai. New York, USA | pt_BR |
| Affilliation | Institute of Human Virology. Baltimore, USA | pt_BR |
| Affilliation | Imperial College. London, UK | pt_BR |
| Affilliation | University of Tokyo. Tokyo, Japan | pt_BR |
| Affilliation | St. Marianna University School of Medicine. Kanagawa, Japan | pt_BR |
| Subject | HTLV-1 | pt_BR |
| Subject | Vaccine | pt_BR |
| Embargo date | 2023-01-01 | |
| xmlui.metadata.dc.subject.ods | 03 Saúde e Bem-Estar | |
